AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇷🇼
Erythromycin Stearate BP in Rwanda
2 products registered with RDA — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| ERYTHROKANT Suspension | Rwanda FDA-HMP-MA-1755 | S KANT HEALTHCARE LTD | active | 16 Aug 2029 |
| EROCIN250 Tablets | Rwanda FDA-HMP-MA-1573 | MAXTAR BIO-GENECS K | active | 16 Aug 2029 |
Erythromycin Stearate BP — RDA Registration Details
RDA (Rwanda) has 2 registered products containing Erythromycin Stearate BP, of which 2 are currently active. Data is sourced directly from the official RDA drug register and refreshed daily.
Track Erythromycin Stearate BP registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.